Consolidated Financial Results for the Three Months Ended March 31,2025 <under IFRS>5/7TDnetPDF(309KB)
Notice regarding the transfer of JT Group’s Pharmaceutical Business through a company simplified absorption-type split5/7TDnetPDF(48KB)
MATERIALS CONCERNING NOTICE OF CONVOCATION OF THE 40TH ORDINARY GENERAL MEETING OF SHAREHOLDERS3/4TDnetPDF(304KB)